Article
ACLY is a prognostic biomarker of head and neck squamous carcinoma
2023-09-01
Abstract excerpt
<h4>Background: </h4> ATP-citrate lyase (ACLY) is considered to be a tumor promoter in multiple human cancers. However, the mechanism of ACLY in head and neck squamous carcinoma (HNSC) progression is unclear. Methods ACLY expression in pan-cancer was analyzed by combining TCGA and GTEx databases. The correlation between ACLY expression and HNSC patients’ prognosis were analyzed by Kaplan-Meier curve. The relation...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6660236c-828d-5b73-9b34-51775101f682
- DOI
- 10.21203/rs.3.rs-3209396/v1
